A new study suggests that semaglutide, the active ingredient in Ozempic, may help decrease liver fat, inflammation, and ...

GLP-1 RA helped resolution of steatohepatitis without worsening fibrosis and reduced liver fibrosis without worsening ...

Weekly 2.4 mg semaglutide was linked to improved liver histology results but did not significantly reduce body pain compared ...

A game-changing medication known for diabetes and weight loss might also hold the key to improving liver health for millions of Americans.

New research reveals that semaglutide significantly improves liver health in MASH patients. A new study published in the New ...

According to a new major clinical trial known as the ESSENCE trial, semaglutide—better known as Ozempic when used for Type 2 ...

Naim Alkhouri, MD, spoke to the potential for glucagon-like peptide-1 (GLP-1) receptor agonists to transform the treatment ...

However, many on Wall Street believe that better days lie ahead for Novo Nordisk. Analysts expect this obesity drug stock to ...

A major international study has found that semaglutide, a drug already used to treat type 2 diabetes and obesity, can ...

A weekly dose of semaglutide, a drug used to manage diabetes and weight loss, was effective in 63% of patients at treating a ...

“This is crucial, given the strong link between MASH and cardiovascular, metabolic, and renal conditions, where semaglutide ...